Atossa Genetics Inc(ATOS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ATOS Atossa Genetics Inc

休市中 07-19 16:00:00 EDT

1.34

-0.02

-1.47%

盘后1.38

+0.04+2.97%

19:10 EDT

最高1.38	最低1.31	成交量68.40万
今开1.36	昨收1.36	日振幅5.15%
总市值1.69亿	流通市值1.58亿	总股本1.26亿
成交额91.39万	换手率0.58%	流通股本1.18亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ATOS","market":"US","secType":"STK","nameCN":"Atossa Genetics Inc","latestPrice":1.34,"timestamp":1721419200000,"preClose":1.36,"halted":0,"volume":683981,"hourTrading":{"tag":"盘后","latestPrice":1.3798,"preClose":1.34,"latestTime":"19:10 EDT","volume":30937,"amount":41932,"timestamp":1721430642009},"delay":0,"floatShares":117921509,"shares":125757416,"eps":-0.2361,"marketStatus":"休市中","marketStatusCode":7,"change":-0.02,"latestTime":"07-19 16:00:00 EDT","open":1.36,"high":1.38,"low":1.31,"amount":913926.3836508,"amplitude":0.051471,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.2361,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1721635200000},"adr":0,"listingDate":1352350800000,"adjPreClose":1.36,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":1.37,"preClose":1.36,"latestTime":"09:29 EDT","volume":3867,"amount":5184.7800186,"timestamp":1721395799999},"postHourTrading":{"tag":"盘后","latestPrice":1.3798,"preClose":1.34,"latestTime":"19:10 EDT","volume":30937,"amount":41932,"timestamp":1721430642009},"volumeRatio":0.5613440525853268,"impliedVol":0.2368,"impliedVolPercentile":0.004},"requestUrl":"/m/hq/s/ATOS/wiki","defaultTab":"wiki","newsList":[{"id":"2451671548","title":"Atossa Therapeutics, Inc.盘中异动 下午盘股价大涨5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451671548","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451671548?lang=zh_cn&edition=full","pubTime":"2024-07-16 02:20","pubTimestamp":1721067615,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日02时20分，Atossa Therapeutics, Inc.股票出现异动，股价急速上涨5.34%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。其相关个股中，Protagenic Therapeutics Inc C/Wts 29/04/2026 、Revolution Medicines Inc C/Wts 17/12/2026 、Aeon Biopharma, Inc.涨幅较大，Scinai Immunotherapeutics Ltd、Qualigen Therapeutics, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为3355.16%、166.16%、137.58%，振幅较大的相关个股有Aeon Biopharma, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Scinai Immunotherapeutics Ltd，振幅分别为150.36%、110.42%、91.37%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716022016941f719d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716022016941f719d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ATOS","ATOWW"],"gpt_icon":0},{"id":"2451156626","title":"法国科技公司Atos(ATOS) 获16.75亿欧元资金用于债务重组","url":"https://stock-news.laohu8.com/highlight/detail?id=2451156626","media":"金吾财讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451156626?lang=zh_cn&edition=full","pubTime":"2024-07-15 16:39","pubTimestamp":1721032747,"startTime":"0","endTime":"0","summary":"金吾财讯 | 法国IT服务提供商源讯(ATOS)7月15日宣布，财务重组计划成功融资。一组银行和一组债券持有人承诺提供16.75亿欧元的定向新担保融资，其余债权人有机会在2024年7月22日之前参与该协议。此外源讯还表示，已获得8亿欧元临时融资，为财务重组计划结束前的业务提供了必要的流动资金。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210625/M2Q5ZDNjNTVmZWY0N2M2OWQ2MzcwMDEwMjQwZGE3NDA2MTUwMTI2NjQy.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/M2Q5ZDNjNTVmZWY0N2M2OWQ2MzcwMDEwMjQwZGE3NDA2MTUwMTI2NjQy.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"277752","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATOS","EUO","FXE","EURmain","MEURmain"],"gpt_icon":0},{"id":"2450753992","title":"Atossa Therapeutics, Inc.盘中异动 早盘股价大涨5.47%报1.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450753992","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450753992?lang=zh_cn&edition=full","pubTime":"2024-07-12 21:44","pubTimestamp":1720791861,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日21时44分，Atossa Therapeutics, Inc.股票出现异动，股价大幅上涨5.47%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.98%。其相关个股中，Qualigen Therapeutics, Inc.、Zura Bio Limited C/Wts 、Instil Bio, Inc.涨幅较大，Qualigen Therapeutics, Inc.、Clearmind Medicine Inc.、Kazia Therapeutics Limited较为活跃，换手率分别为1005.32%、82.96%、33.46%，振幅较大的相关个股有Qualigen Therapeutics, Inc.、Zura Bio Limited C/Wts 、Kazia Therapeutics Limited，振幅分别为75.45%、20.00%、16.53%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712214421af921d3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712214421af921d3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ATOS","ATOWW","BK4139"],"gpt_icon":0},{"id":"2449368709","title":"Atossa Therapeutics, Inc.盘中异动 早盘股价大涨5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449368709","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449368709?lang=zh_cn&edition=full","pubTime":"2024-07-08 22:17","pubTimestamp":1720448220,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日22时17分，Atossa Therapeutics, Inc.股票出现波动，股价快速上涨5.50%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.72%。其相关个股中，Virpax Pharmaceuticals, Inc.、Morphic Holding, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Virpax Pharmaceuticals, Inc.、Cero Therapeutics Holdings, Inc.、Kineta, Inc.较为活跃，换手率分别为1257.88%、167.77%、137.52%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Cero Therapeutics Holdings, Inc.、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为74.39%、36.60%、34.48%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407082217019681aab6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407082217019681aab6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATOWW","LENZ","ATOS"],"gpt_icon":0},{"id":"2449199293","title":"Atossa Therapeutics, Inc.盘中异动 早盘快速下挫5.13%报1.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449199293","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449199293?lang=zh_cn&edition=full","pubTime":"2024-07-05 21:49","pubTimestamp":1720187384,"startTime":"0","endTime":"0","summary":"北京时间2024年07月05日21时49分，Atossa Therapeutics, Inc.股票出现波动，股价快速下跌5.13%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.27%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。该公司正在开发用于治疗乳腺癌和其他乳腺疾病的药物是Endoxifen。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407052149459681a297&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407052149459681a297&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATOS","LENZ","ATOWW"],"gpt_icon":0},{"id":"2448915373","title":"Atossa Therapeutics, Inc.盘中异动 早盘急速上涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448915373","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448915373?lang=zh_cn&edition=full","pubTime":"2024-07-01 21:40","pubTimestamp":1719841206,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日21时40分，Atossa Therapeutics, Inc.股票出现波动，股价大幅上涨5.04%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。该公司正在开发用于治疗乳腺癌和其他乳腺疾病的药物是Endoxifen。消息层面，截至21时40分，《H.C. Wainwright维持Atossa Therapeutics买入评级，维持目标价6美元》资讯为影响Atossa Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701214006aef76d87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701214006aef76d87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATOS","LENZ","ATOWW"],"gpt_icon":0},{"id":"2446687363","title":"Atossa Therapeutics, Inc.盘中异动 股价大涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446687363","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446687363?lang=zh_cn&edition=full","pubTime":"2024-06-28 23:25","pubTimestamp":1719588337,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日23时25分，Atossa Therapeutics, Inc.股票出现异动，股价急速上涨5.26%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406282325379681809c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406282325379681809c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ATOWW","ATOS","BK4139"],"gpt_icon":0},{"id":"2446140553","title":"Atossa Therapeutics, Inc.盘中异动 早盘大幅上涨5.71%报1.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446140553","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446140553?lang=zh_cn&edition=full","pubTime":"2024-06-27 21:38","pubTimestamp":1719495482,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日21时38分，Atossa Therapeutics, Inc.股票出现波动，股价急速拉升5.71%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。该公司正在开发用于治疗乳腺癌和其他乳腺疾病的药物是Endoxifen。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627213802aef6f05d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627213802aef6f05d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ATOWW","ATOS"],"gpt_icon":0},{"id":"2446395106","title":"Atossa Therapeutics, Inc.盘中异动 早盘快速拉升20.39%报1.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446395106","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446395106?lang=zh_cn&edition=full","pubTime":"2024-06-26 21:30","pubTimestamp":1719408653,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日21时30分，Atossa Therapeutics, Inc.股票出现波动，股价快速上涨20.39%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.79%。其相关个股中，Anew Medical, Inc.、Savara, Inc.、Neurobo Pharmaceuticals, Inc.涨幅较大，Anew Medical, Inc.、Cns Pharmaceuticals, Inc.、Gri Bio, Inc.较为活跃，换手率分别为251.45%、58.59%、55.39%，振幅较大的相关个股有Anew Medical, Inc.、Xortx Therapeutics Inc.、Io Biotech, Inc.，振幅分别为8.76%、5.83%、5.51%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626213053aef6be1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626213053aef6be1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ATOS","ATOWW"],"gpt_icon":0},{"id":"2446004129","title":"Atossa Therapeutics, Inc.盘中异动 股价大跌5.31%报1.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446004129","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446004129?lang=zh_cn&edition=full","pubTime":"2024-06-25 00:42","pubTimestamp":1719247351,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日00时42分，Atossa Therapeutics, Inc.股票出现异动，股价大幅下跌5.31%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.92%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。该公司正在开发用于治疗乳腺癌和其他乳腺疾病的药物是Endoxifen。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625004232941f09c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625004232941f09c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATOS","ATOWW","BK4139","LENZ"],"gpt_icon":0},{"id":"2442557808","title":"Atossa Therapeutics, Inc.盘中异动 早盘急速拉升5.24%报1.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442557808","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442557808?lang=zh_cn&edition=full","pubTime":"2024-06-12 21:31","pubTimestamp":1718199108,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日21时31分，Atossa Therapeutics, Inc.股票出现波动，股价快速上涨5.24%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。该公司正在开发用于治疗乳腺癌和其他乳腺疾病的药物是Endoxifen。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612213148941ee0af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612213148941ee0af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ATOS","ATOWW"],"gpt_icon":0},{"id":"2439657505","title":"Atossa Therapeutics, Inc.盘中异动 股价大跌5.28%报1.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439657505","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439657505?lang=zh_cn&edition=full","pubTime":"2024-05-29 22:34","pubTimestamp":1716993296,"startTime":"0","endTime":"0","summary":"北京时间2024年05月29日22时34分，Atossa Therapeutics, Inc.股票出现波动，股价快速下跌5.28%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.03%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。该公司正在开发用于治疗乳腺癌和其他乳腺疾病的药物是Endoxifen。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529223456941eae94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529223456941eae94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATOWW","LENZ","ATOS"],"gpt_icon":0},{"id":"2438374025","title":"Atossa Therapeutics, Inc.盘中异动 股价大涨5.48%报1.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2438374025","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438374025?lang=zh_cn&edition=full","pubTime":"2024-05-28 21:31","pubTimestamp":1716903063,"startTime":"0","endTime":"0","summary":"北京时间2024年05月28日21时31分，Atossa Therapeutics, Inc.股票出现异动，股价急速拉升5.48%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.82%。其相关个股中，Insmed Incorporated、Calliditas Therapeutics Ab、Exicure, Inc.涨幅较大，Exicure, Inc.、Nls Pharmaceutics Ltd.、Jaguar Health, Inc.较为活跃，换手率分别为17.31%、7.26%、6.65%，振幅较大的相关个股有维罗纳制药、Nuvectis Pharma, Inc.、Renovorx, Inc.，振幅分别为8.52%、7.89%、7.14%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528213103aef21a76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528213103aef21a76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATOWW","LENZ","ATOS","BK4139"],"gpt_icon":0},{"id":"2437173232","title":"Atossa Therapeutics, Inc.盘中异动 股价大跌5.21%报1.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2437173232","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437173232?lang=zh_cn&edition=full","pubTime":"2024-05-23 02:30","pubTimestamp":1716402623,"startTime":"0","endTime":"0","summary":"北京时间2024年05月23日02时30分，Atossa Therapeutics, Inc.股票出现波动，股价大幅下挫5.21%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。该公司正在开发用于治疗乳腺癌和其他乳腺疾病的药物是Endoxifen。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405230230249680f177&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405230230249680f177&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATOWW","LENZ","ATOS","BK4139"],"gpt_icon":0},{"id":"2435551982","title":"Atossa Therapeutics, Inc.盘中异动 早盘大幅上涨5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435551982","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435551982?lang=zh_cn&edition=full","pubTime":"2024-05-14 21:43","pubTimestamp":1715694238,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日21时43分，Atossa Therapeutics, Inc.股票出现波动，股价快速拉升5.48%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Nutriband Inc C/Wts 、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Allarity Therapeutics, Inc.、Transcode Therapeutics, Inc.、Scorpius Holdings, Inc.较为活跃，换手率分别为53.40%、10.13%、8.95%，振幅较大的相关个股有Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Transcode Therapeutics, Inc.、Imunon, Inc.，振幅分别为33.57%、21.54%、17.57%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405142143597a59d934&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405142143597a59d934&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATOWW","ATOS","BK4139","LENZ"],"gpt_icon":0},{"id":"2434863423","title":"Atossa Therapeutics, Inc.盘中异动 股价大跌5.25%报1.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434863423","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434863423?lang=zh_cn&edition=full","pubTime":"2024-05-10 23:24","pubTimestamp":1715354699,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日23时24分，Atossa Therapeutics, Inc.股票出现波动，股价快速下挫5.25%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。该公司正在开发用于治疗乳腺癌和其他乳腺疾病的药物是Endoxifen。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051023245987e87272&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051023245987e87272&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATOWW","ATOS","LENZ"],"gpt_icon":0},{"id":"2433722610","title":"Atossa Therapeutics, Inc.盘中异动 早盘大幅上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433722610","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433722610?lang=zh_cn&edition=full","pubTime":"2024-05-08 22:23","pubTimestamp":1715178184,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日22时23分，Atossa Therapeutics, Inc.股票出现异动，股价大幅上涨5.00%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。其相关个股中，Sab Biotherapeutics Inc C/Wts 22/10/2026 、Cel-Sci Corporation、Effector Therapeutics Inc C/Wts 31/12/2025 涨幅较大，Enveric Biosciences, Inc.、Allarity Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为229.97%、55.27%、24.13%，振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Chemomab Therapeutics Ltd，振幅分别为60.74%、43.00%、33.42%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405082223047a58c4db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405082223047a58c4db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ATOWW","ATOS","BK4139"],"gpt_icon":0},{"id":"2433716964","title":"Atossa Therapeutics, Inc.盘中异动 股价大涨6.02%报1.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433716964","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433716964?lang=zh_cn&edition=full","pubTime":"2024-05-06 21:35","pubTimestamp":1715002524,"startTime":"0","endTime":"0","summary":"北京时间2024年05月06日21时35分，Atossa Therapeutics, Inc.股票出现异动，股价急速上涨6.02%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Tc Biopharm  Plc、Nrx Pharmaceuticals, Inc.、Chemomab Therapeutics Ltd涨幅较大，Allarity Therapeutics, Inc.、Tc Biopharm  Plc、Plus Therapeutics, Inc.较为活跃，换手率分别为533.21%、200.01%、39.93%，振幅较大的相关个股有Tc Biopharm  Plc、Akari Therapeutics Plc、Allarity Therapeutics, Inc.，振幅分别为21.23%、16.90%、13.00%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405062135247a5847f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405062135247a5847f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATOWW","ATOS","LENZ"],"gpt_icon":0},{"id":"2432038049","title":"Atossa Therapeutics, Inc.盘中异动 早盘大幅拉升5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432038049","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432038049?lang=zh_cn&edition=full","pubTime":"2024-05-03 21:49","pubTimestamp":1714744198,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日21时49分，Atossa Therapeutics, Inc.股票出现异动，股价大幅拉升5.26%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032149597925c15c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032149597925c15c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ATOS","ATOWW","BK4139"],"gpt_icon":0},{"id":"2432030246","title":"美国研究综述-万事达卡、Metagenomi、Ziff Davis","url":"https://stock-news.laohu8.com/highlight/detail?id=2432030246","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432030246?lang=zh_cn&edition=full","pubTime":"2024-05-02 20:59","pubTimestamp":1714654793,"startTime":"0","endTime":"0","summary":"    路透5月2日 - 华尔街证券分析师周四调整了对万事达卡、Metagenomi 和 Ziff Davis 等几家美国上市公司的评级和目标价。* 万事达卡公司  ：摩根大通将目标价从520美元下调至510美元 * Metagenomi Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BALY","ARAY","LU0353189680.USD","ASTH","BLCO","BK4532","AMD","ACHC","ATRC","BXC","APP","AN","AMT","ADP","AMPY","AVT","ASH","BK4534","AEP","AEIS","AXTA","BMRC","ABG","IE00B1XK9C88.USD","ASTE","ASB","AWH","ALB","AWI","F","BK4227","BK4539","MA","ALKT","AMZN","AFL","APD","AX","GOLD","MGX","ALL","ARCC","TECH","APA","LU0211327993.USD","TCPC","BK4220","ARCB","ATOS","AROC"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.atossatherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0229},{"period":"1month","weight":0.1964},{"period":"3month","weight":-0.0219},{"period":"6month","weight":0.6341},{"period":"1year","weight":0.1754},{"period":"ytd","weight":0.5227}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Atossa Therapeutics, Inc.于2009年4月30日在特拉华州注册成立。他们是一家临床阶段的生物制药公司，致力于在肿瘤学和传染病的重大未满足医疗需求领域发现和开发创新药物，目前专注于乳腺癌，其他乳房状况和COVID-19。他们正在开发的治疗乳腺癌和其他乳腺疾病的药物是Endoxifen，主要在两种情况下开发：一种是在乳腺癌诊断和手术之间的“机会窗口”中降低乳腺癌患者的肿瘤细胞活性；另一种适用于乳房组织致密的女性，以降低密度。他们正在开发的两种COVID-19药物是AT-H201，用于通过吸入改善中度至重度住院COVID-19患者的肺功能；和AT-301，一种供COVID-19患者在家使用的鼻腔喷雾剂。他们的业务战略是通过包括合作伙伴在内的临床研究来推进他们的项目，并通过收购、合作或内部开发机会性地在未满足的医疗需求领域增加项目。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.32737},{"month":2,"riseRate":0.583333,"avgChangeRate":0.115141},{"month":3,"riseRate":0.416667,"avgChangeRate":0.101791},{"month":4,"riseRate":0.25,"avgChangeRate":-0.074599},{"month":5,"riseRate":0.416667,"avgChangeRate":-0.004454},{"month":6,"riseRate":0.583333,"avgChangeRate":0.133936},{"month":7,"riseRate":0.166667,"avgChangeRate":-0.119439},{"month":8,"riseRate":0.272727,"avgChangeRate":-0.062727},{"month":9,"riseRate":0.181818,"avgChangeRate":-0.049565},{"month":10,"riseRate":0.090909,"avgChangeRate":-0.211226},{"month":11,"riseRate":0.363636,"avgChangeRate":-0.047831},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.103392}],"exchange":"NASDAQ","name":"Atossa Genetics Inc","nameEN":"Atossa Genetics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Atossa Genetics Inc(ATOS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Atossa Genetics Inc(ATOS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Atossa Genetics Inc,ATOS,Atossa Genetics Inc股票,Atossa Genetics Inc股票老虎,Atossa Genetics Inc股票老虎国际,Atossa Genetics Inc行情,Atossa Genetics Inc股票行情,Atossa Genetics Inc股价,Atossa Genetics Inc股市,Atossa Genetics Inc股票价格,Atossa Genetics Inc股票交易,Atossa Genetics Inc股票购买,Atossa Genetics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Atossa Genetics Inc(ATOS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Atossa Genetics Inc(ATOS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}